1. "Lymphoma"
Formats
  1. Meeting Abstract (1340)
  2. Journal Article (1048)
  3. Book Section (63)
  4. Review (63)
  5. Editorial (37)
  6. Research Letter (35)
  7. Guidelines (18)
  8. Conference Paper (15)
  9. Correspondence (11)
  10. Miscellaneous (5)
  11. Book Whole (4)
Groups
  1. Center for Hematologic Malignancies (2639)
  2. Department of Medicine (2639)
  3. Hematologic Malignancies, Division of (2639)
  4. Lymphoma (2639)
  5. Population Sciences Research Program (720)
  6. Survivorship Research (633)

More Groups

People
  1. Andrew Zelenetz (767)
  2. Steven Horwitz (645)
  3. Maria Palomba (415)
  4. David Straus (356)
  5. Ariela Noy (351)
  6. Alison Moskowitz (339)

More People

Years
  1. 2025 (28)
  2. 2024 (100)
  3. 2023 (180)
  4. 2022 (170)
  5. 2021 (171)
  6. 2020 (170)

More Years

Publications
  1. Blood (833)
  2. Journal of Clinical Oncology (274)
  3. Hematological Oncology (110)
  4. Leukemia and Lymphoma (81)
  5. British Journal of Haematology (79)
  6. Haematologica (71)

More Publications

Publishers
  1. American Society of Hematology (898)
  2. American Society of Clinical Oncology (290)
  3. Elsevier Inc. (187)
  4. Wiley Blackwell (173)
  5. John Wiley & Sons (95)
  6. Nature Publishing Group (92)

More Publishers

Results (2639)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Allogeneic hematopoietic cell transplant (alloHCT) for hematologic malignancies in human immunodeficiency virus infected (HIV) patients (pts): Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0903)/AIDS Malignancy Consortium (AMC-080) trial
    Meeting Abstract

    Ambinder, R. F.; Wu, J.; Logan, B.; Durand, C.; Shields, R.; Popat, U. R.; Little, R. F.; McMahon, D.; Mellors, J. W.; Ayala, E.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • CR rates in relapsed/refractory (R/R) aggressive B-NHL treated with the CD19-directed CAR T-cell product JCAR017 (TRANSCEND NHL 001)
    Meeting Abstract

    Abramson, J. S.; Palomba, M. L.; Gordon, L. I.; Lunning, M. A.; Arnason, J. E.; Forero-Torres, A.; Wang, M.; Albertson, T. M.; Allen, T.; Sutherland, C.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Lupus-related single nucleotide polymorphisms and risk of diffuse large B-cell lymphoma
    Journal Article

    Bernatsky, S.; Garcia, H. A. V.; Spinelli, J. J.; Gaffney, P.; Smedby, K. E.; Ramsey-Goldman, R.; Wang, S. S.; Adami, H. O.; Albanes, D.; Angelucci, E.; more...
    Lupus Science & Medicine (2017)

    Fulltext@MSK | Save
  • Highlights in lymphoma from the 2016 American Society of Hematology Annual Meeting and Exposition: Commentary
    Journal Article

    Horwitz, S. M.
    Clinical Advances in Hematology & Oncology (2017)

    Fulltext@MSK | Save
  • Safety and efficacy of atezolizumab in combination with obinutuzumab and bendamustine in patients with previously untreated follicular lymphoma: An interim analysis
    Meeting Abstract

    Younes, A.; John, B. M.; Diefenbach, C. S.; Ferrari, S.; Kahn, C.; Sharman, J. P.; Tani, M.; Ujjani, C. S.; Vitolo, U.; Yuen, S.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Safety and efficacy of the combination of ibrutinib and nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukemia
    Meeting Abstract

    Younes, A.; Brody, J.; Carpio, C.; Lopez-Guillermo, A.; Ben-Yehuda, D.; Ferhanoglu, A. B.; Nagler, A.; Ozcan, M.; Avivi, I.; Albareda, F. B.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Spliceosomal dysfunction Is a critical mediator of IDH2 mutant leukemogenesis
    Meeting Abstract

    Yoshimi, A.; Lin, K. T.; Wiseman, D.; Intlekofer, A. M.; Wang, B.; Pastore, A.; Rahman, M.; Lee, S. C. W.; Liu, B.; Micol, J. B.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Measurement of PD-1 expression on lymphoma cells by flow cytometry is a useful tool in diagnosing and monitoring minimal residual disease in angioimmunoblastic T-cell lymphoma
    Meeting Abstract

    Yabe, M.; Ozkaya, N.; Gao, Q.; Pichardo, J.; Huet, S.; Moskowitz, A. J.; Horwitz, S. M.; Dogan, A.; Roshal, M.
    Blood (2017)

    Fulltext@MSK | Save
  • WhiMSICAL (Waldenström's Macroglobulinemia Study Involving CArt-wheeL): Empowering patients internationally to contribute patient-derived data for observational research
    Meeting Abstract

    Tohidi-Esfahani, I.; Warden, A.; deNardis, P.; Malunis, E.; D'Sa, S.; Kersten, M. J.; Palomba, M. L.; Spearing, R.; Ysebaert, L.; Thomas, S. K.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Long-term follow-up of previously treated patients who received ibrutinib for symptomatic Waldenstrom's Macroglobulinemia: Update of pivotal clinical trial
    Meeting Abstract

    Treon, S. P.; Meid, K.; Gustine, J.; Bantilan, K. S.; Dubeau, T.; Severns, P.; Yang, G.; Xu, L.; Patterson, C.; Ghobrial, I. M.; more...
    Blood (2017)

    Fulltext@MSK | Save